Literature DB >> 22409565

Demographic, clinical, and ocular features in patients with late-onset Behçet disease.

Dicle Hazirolan1, Gulten Sungur, Sunay Duman.   

Abstract

PURPOSE: To evaluate demographic, clinical, and ocular features of patients with late-onset Behçet disease (BD).
METHODS: The study included 26 patients with late-onset BD. Onset of their first symptoms was before age 40. They fulfilled the diagnostic criteria after age 40. Patients were divided into 2 groups: group 1 had uveitis and group 2 had no uveitis. Clinical and demographic features of the groups were compared. Ocular manifestations in group 1 were also evaluated.
RESULTS: Fourteen patients (53.8%) had uveitis and 12 patients (46.2%) had no ocular involvement. The incidence of genital ulcer was higher in group 1. Twelve patients (18 eyes) had anterior uveitis and 2 patients (4 eyes) had panuveitis. The incidence of anterior uveitis was higher in females. The incidence of panuveitis was higher in males.
CONCLUSIONS: As compared to potentially devastating posterior uveitis, anterior uveitis is more often encountered in patients with late-onset BD. Hence, with respect to ocular involvement, the prognosis is better.

Entities:  

Mesh:

Year:  2012        PMID: 22409565     DOI: 10.3109/09273948.2012.655882

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  3 in total

Review 1.  [Behçet's disease - ophthalmological and general aspects part I : etiology, pathogenesis and diagnostics].

Authors:  U Pleyer; D Hazirolan; S Winterhalter; N Stübiger
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

2.  Vision-Threatening Behcet's Disease: Severity of Ocular Involvement Predictors.

Authors:  Mohammed A Hussein; Iman M Eissa; Ahmed A Dahab
Journal:  J Ophthalmol       Date:  2018-04-26       Impact factor: 1.909

3.  Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51.

Authors:  Hee Jung Ryu; Mi Ryoung Seo; Hyo Jin Choi; Han Joo Baek
Journal:  Korean J Intern Med       Date:  2017-01-12       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.